|
Biological Activity:
D2 dopamine receptor antagonist; MAO inhibitor; a therapeutic antipsychotic, used in the treatment of schizophrenia; Reduction of body weight reported. Terminal plasma half-life after oral administration about 6½ hours.
References: online
A Bagnall et al. Molindone for schizophrenia and severe mental illness. Cochrane Database Syst. Rev. 2007, 1, CD002083. [online]
DB Allison et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry 1999, 156(11), 1686–1696. [abstract] [online]
Chemical Name: 3-Ethyl-2-methyl-5-morpholin-4-ylmethyl-1,5,6,7-tetrahydro-indol-4-one hydrochloride
|